A Patient-Centric Approach to Improving the Recognition and Diagnosis of Binge Eating Disorder

0.75 CME
$0 FEE
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Images of faceless frustrated people


Provider Statement

Jointly provided by Postgraduate Institute for Medicine and Catamount Medical Education.

Support Statement

This activity is supported by an independent educational grant from Takeda.

  • Release Date: April 21, 2021
  • Expiration Date: April 21, 2022

Estimated Time to Complete Activity

45 minutes

Target Audience

This activity is intended for primary care clinicians, psychiatrists, and other healthcare professionals who may be involved in the diagnosis of BED.

Learning Objectives

After completing this activity, the participant should be better able to:

  • Discuss misperceptions associated with BED
  • Summarize data on, and the impact on patients from the underrecognition and underdiagnosis of BED
  • Apply the latest diagnostic criteria to support the identification of BED
  • Review best practices for communicating with patients regarding the diagnosis of BED


Tracy S. Cummings, MD
Psychiatrist, Lindner Center of HOPE
Chief of Child and Adolescent Psychiatry
Medical Director of CCHMC Services At LCOH
Assistant Professor of Clinical Geo,
University of Cincinnati College of Medicine

Planning Committee

Susan Denner, MD, MS, Medical Director, Catamount Medical Education
Danielle Ellinas, Project Manager, Catamount Medical Education

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high-quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships with ineligible entities related to the educational content of this CE activity:

Dr. Cummings has no relationships to disclose.

Reviewers report the following relationship(s)

The PIM planners and managers have nothing to disclose. The Catamount Medical Education planners and managers have nothing to disclose.

Joint Accreditation Statement

Jointly Accredited Provider Logo 

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Catamount Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All other healthcare professionals completing this course will be issued a statement of participation.

How to Participate in This Activity and Obtain CME Credit

There are no fees for participating and receiving CME/CE credit for this activity. During the period of April 21, 2021, through April 21, 2022, participants must read the learning objectives and faculty disclosures, study the educational activity, and complete the post-test and evaluation.



Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.